e-learning
resources
London 2016
Tuesday, 06.09.2016
Exploring mechanisms in health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Performance characteristics of an ECL immunoassay for the quantitation of serum periostin
Stefan Palme (Penzberg, Germany), Stefan Palme, Robert H. Christenson, Saeed A. Jortani, Richard E. Ostlund, Ruediger Kolm, Guido Kopal, Ruediger P. Laubender
Source:
International Congress 2016 – Exploring mechanisms in health and disease
Session:
Exploring mechanisms in health and disease
Session type:
Poster Discussion
Number:
3448
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stefan Palme (Penzberg, Germany), Stefan Palme, Robert H. Christenson, Saeed A. Jortani, Richard E. Ostlund, Ruediger Kolm, Guido Kopal, Ruediger P. Laubender. Performance characteristics of an ECL immunoassay for the quantitation of serum periostin. Eur Respir J 2016; 48: Suppl. 60, 3448
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Performance evaluation of a novel point-of-care total IgE assay system in atopic patients
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
A new investigational use only automated immunoassay for periostin
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Usefulness of periostin as a biomarker of pediatric asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
A scoring algorithm for predicting the presence of adult asthma
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Assessment of serum magnesium level in patients with bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Routine serum protein electrophoresis and detection of alpha
1
-antitrypsin deficiency
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Refined severity assessment of asthmatic children using molecular allergy diagnostics
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
COPD and the asthma-COPD-overlap-syndrome
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Clustering analysis of clinical variables in U-BIOPRED adult asthma cohort
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Asthma control index in European countries: The LIAISON (InternationaL cross-sectIonAl and longitudinal assessment on aSthma cONtrol) study cross-sectional results
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept